Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging

The objective of this study is to explore the integration of in vivo and ex vivo of MRI with histology and molecular assessments to advance non-invasive characterization of tumor heterogeneity in high-grade serous ovarian cance

Trial Details

NCT ID
NCT06084195
Phase
NA
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Status
RECRUITING
Cancer Type
High-Grade Serous Ovarian Cancer
Interventions
  • Blood sample and tissue sample
Locations (sample)
  • Montpellier, France|43.61093,3.87635

Key Eligibility Criteria

  • Patient aged \>18
  • Pathologically proven HGSOC at an advanced stage (FIGO IIIB or IIIC) which can benefit from surgery with or without prior neoadjuvant treatment
  • Willingness and ability to comply with planned visits, treatment plan, laboratory tests and other study procedures,
  • Patient who has given informed, written and express consent,

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find High-Grade Serous Ovarian Cancer Trials on Trialify →